Cargando…

Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing

A new pandemic is ongoing in several parts of the world. The agent responsible is the newly emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The symptoms associated with this virus are known as the coronavirus disease-2019 (COVID-19). In this review, we summarize the published d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahalingam, Sundarasamy, Peter, John, Xu, Ziyang, Bordoloi, Devivasha, Ho, Michelle, Kalyanaraman, Vaniambadi S., Srinivasan, Alagarsamy, Muthumani, Kar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052472/ https://www.ncbi.nlm.nih.gov/pubmed/33898857 http://dx.doi.org/10.1016/j.heliyon.2021.e06836

Ejemplares similares

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021)

A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: Potential impact on CTL epitopes
por: Srinivasan, Alagarsamy, et al.
Publicado: (2008)

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Choi, Hyeree, et al.
Publicado: (2021)

Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2
por: Saini, Pratima, et al.
Publicado: (2023)

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus
por: Choi, Hyeree, et al.
Publicado: (2020)

Interplay between human nucleolar GNL1 and RPS20 is critical to modulate cell proliferation
por: Krishnan, Rehna, et al.
Publicado: (2018)

Viral protein X unlocks the nuclear pore complex through a human Nup153-dependent pathway to promote nuclear translocation of the lentiviral genome
por: Singh, Satya Prakash, et al.
Publicado: (2020)

Guanine nucleotide binding protein like-1 (GNL1) promotes cancer cell proliferation and survival through AKT/p21 (CIP1) signaling cascade
por: Krishnan, Rehna, et al.
Publicado: (2020)

Discrete SARS-CoV-2 antibody titers track with functional humoral stability
por: Bartsch, Yannic C., et al.
Publicado: (2021)

The landscape of antibody binding in SARS-CoV-2 infection
por: Heffron, Anna S., et al.
Publicado: (2021)

Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients
por: Cheng, Linlin, et al.
Publicado: (2021)

Molecular basis for RASSF10/NPM/RNF2 feedback cascade–mediated regulation of gastric cancer cell proliferation
por: Lakshmi Ch, Naga Padma, et al.
Publicado: (2021)

SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients
por: Walker, Susanne N., et al.
Publicado: (2020)

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
por: Chung, Christopher, et al.
Publicado: (2023)

Usefulness of IVD Kits for the Assessment of SARS-CoV-2 Antibodies to Evaluate the Humoral Response to Vaccination
por: Lukaszuk, Krzysztof, et al.
Publicado: (2021)

Global Quantitative Proteomics reveal Deregulation of Cytoskeletal and Apoptotic Signalling Proteins in Oral Tongue Squamous Cell Carcinoma
por: Ananthi, Sivagnanam, et al.
Publicado: (2018)

Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
por: Carrillo, Jorge, et al.
Publicado: (2021)

DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond
por: Maslow, Joel N., et al.
Publicado: (2023)

Humoral Immune Response to SARS-CoV-2 in Iceland
por: Gudbjartsson, Daniel F., et al.
Publicado: (2020)

Humoral Response to SARS-CoV-2 in Hemodialysis Patients
por: Steers, Nicholas J.
Publicado: (2021)

Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain
por: Wheatley, Adam K., et al.
Publicado: (2021)

GNL3L Is a Nucleo-Cytoplasmic Shuttling Protein: Role in Cell Cycle Regulation
por: Thoompumkal, Indu Jose, et al.
Publicado: (2015)

SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
por: Dogan, Mikail, et al.
Publicado: (2021)

Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community
por: Kotsiou, Ourania S., et al.
Publicado: (2021)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
por: Prendecki, Maria, et al.
Publicado: (2021)

Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets
por: Hachim, Asmaa, et al.
Publicado: (2021)

The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution
por: Moulana, Alief, et al.
Publicado: (2023)

Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals
por: Cheedarla, Narayanaiah, et al.
Publicado: (2017)

Humoral Responses and Serological Assays in SARS-CoV-2 Infections
por: Galipeau, Yannick, et al.
Publicado: (2020)

Realization of humoral immunity against SARS-CoV-2 infections
por: Lin, Yong, et al.
Publicado: (2021)

Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
por: Taefehshokr, Nima, et al.
Publicado: (2020)

HUMORAL IMMUNITY IN PATIENTS WITH SARS-COV-2 INFECTION: A REVIEW
por: Ogundipe, H.D.
Publicado: (2021)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

Waning and boosting of functional humoral immunity to SARS-CoV-2
por: Tong, X., et al.
Publicado: (2022)

Immunological imprinting of humoral immunity to SARS-CoV-2 in children
por: Dowell, Alexander C., et al.
Publicado: (2023)

Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay
por: Nam, Minjeong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rqpkdfr52mot2k8pofo2i5kgf3